1. Home
  2. FRPT vs VCYT Comparison

FRPT vs VCYT Comparison

Compare FRPT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshpet Inc.

FRPT

Freshpet Inc.

HOLD

Current Price

$59.96

Market Cap

3.0B

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$43.36

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPT
VCYT
Founded
2004
2006
Country
United States
United States
Employees
1288
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
FRPT
VCYT
Price
$59.96
$43.36
Analyst Decision
Buy
Strong Buy
Analyst Count
17
7
Target Price
$76.94
$44.00
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
183.87
164.52
EPS
1.29
0.66
Revenue
$1,102,015,000.00
N/A
Revenue This Year
$11.34
$13.76
Revenue Next Year
$9.13
$12.35
P/E Ratio
$47.57
$62.91
Revenue Growth
13.01
N/A
52 Week Low
$46.45
$29.46
52 Week High
$86.00
$60.91

Technical Indicators

Market Signals
Indicator
FRPT
VCYT
Relative Strength Index (RSI) 32.82 45.06
Support Level $58.54 $40.80
Resistance Level $67.21 $42.98
Average True Range (ATR) 2.33 1.99
MACD -1.00 0.17
Stochastic Oscillator 9.11 41.19

Price Performance

Historical Comparison
FRPT
VCYT

About FRPT Freshpet Inc.

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: